PCDH9 _CESC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS20000062
Fusion event
HPV-PCDH9 integration
Validated
Yes
Detection method
PCR and Sanger sequencing
Data source
Curated
Sample type
Disease
Cervical carcinoma (CC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HPV
Subtype
HPV16
Reference genome
Region type
E1
Start
2744
Integrated sequence
CACACCACTAAGTTGTTGCACAGAGACTCAGTGGACAGTGCTCCAATCCTCACTGCATTTAACAGCTCACACAAAGGACGGATTAACTGTAATAGTAACA| |CTACACCCATAGTACATTTAAAAGGTGATGCTAATACTTTAAAATGTTTAAGATATAGATTTAAAAAGCATTGTACATTGTATACTGCAGTGTCGTCTAC
Host Sequence
Chromosome
chr13
Cytoband
q21.32
Reference genome
End
67500034/66925902 (Hg38)
Location type
Intronic
Fragile sites / regions
Target gene
Nearest miRNA
hsa-mir-1297/Upstream/707578; hsa-mir-1267/Downstream/10772110;
Nearest cancer related gene
PCDH9(TSG, No orient, 0)
Upstream sequence
tATTATGATAATGATTATTACATTAATTTCCATAAATTTGTGATTGAAGAGTTCCCAGTTGCCTTTGGGAAAAAAAAAAAAAGCTTTAATGCGACCTAGT
Downstream sequence
GGCCTTTTAAAATATATTTGTGTCCTTCTGAAGATCAGAGGGGGCATGACTTCAGCAGGTCTTGGAGCATATGACATTGTTCATGTCCATTGTCTTCCTA
Reference
Liu, Y., et al. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology. Oncotarget,2016, 7(5): 5852-5864.
Curate